Pharmaguy's Insights Into Drug Industry News
185.8K views | +29 today
Follow
Pharmaguy's Insights Into Drug Industry News
Pharmaguy curates and provides insights into selected drug industry news and issues.
Curated by Pharma Guy
Your new post is loading...
Your new post is loading...
Scooped by Pharma Guy
Scoop.it!

Pharma Industry Reputation Hits 7-Year Low According to Harris Poll

Pharma Industry Reputation Hits 7-Year Low According to Harris Poll | Pharmaguy's Insights Into Drug Industry News | Scoop.it

The line chart illustrates the decline of pharma’s reputation, which puts it on par with its consumer perceptions in 2010 — just before Medicare Part D was legislated and implemented, which improved pharma’s image among American health citizens (especially older patients who tend to be more frequent consumers of prescription drugs).

 

Further Reading:

Pharma Guy's insight:

Public relations efforts by the industry fails to reverse the trend!

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

Harris Poll: Only Nine Percent of U.S. Consumers Believe Pharma and Biotechnology Put Patients over Profits; Only 16 Percent Believe Health Insurers Do

Harris Poll: Only Nine Percent of U.S. Consumers Believe Pharma and Biotechnology Put Patients over Profits; Only 16 Percent Believe Health Insurers Do | Pharmaguy's Insights Into Drug Industry News | Scoop.it

Only nine percent of U.S. consumers believe pharmaceutical and biotechnology companies put patients over profits, while only 16 percent believe health insurance companies do, according to a Harris Poll® study released today. Meanwhile, 36 percent of U.S. adults believe health care providers (such as doctors and nurses) put patients over profits, compared to hospitals (23%).

 

"We are in the midst of a health care maelstrom," said Wendy Salomon, vice president of reputation management and public affairs at Nielsen. "Consumers see no safe port, no place where their interests are truly protected-and that lack of consumer trust is reflected in the reputational risk we see across the U.S. health care landscape."

 

Additionally, the Harris Poll of more than 1,000 U.S. adults ages 18+ indicates that while most are neutral toward health care industries, more consumers rate health insurance (24%) and pharmaceutical and biotechnology companies (20%) with low reputations, compared to hospitals (6%), health care providers (doctors and nurses) (5%) and technology (2%). Fifty-eight percent rate the reputation of the technology industry as high, compared to health care providers (43%), hospitals (37%), pharmaceutical and biotechnology companies (20%), and health insurance companies (15%).

 

"There are undeniable reputational risks for pharmaceutical and health insurance companies – more so than other parts of the health care ecosystem," said Salomon. "Reputation matters to patients, care providers, investors, employees, and potential hires. Positive reputations can pave the way in times of crisis, in times of transition – and when it's critical to have a seat at the policy-setting table."

 

Further Reading:

more...